Cargando…
Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
Autores principales: | Ye, Ting-Hong, Yang, Fang-Fang, Zhu, Yong-Xia, Li, Ya-Li, Lei, Qian, Song, Xue-Jiao, Xia, Yong, Xiong, Ying, Zhang, Li-Dan, Wang, Ning-Yu, Zhao, Li-Feng, Gou, Hong-Feng, Xie, Yong-Mei, Yang, Sheng-Yong, Yu, Luo-Ting, Yang, Li, Wei, Yu-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763466/ https://www.ncbi.nlm.nih.gov/pubmed/31558703 http://dx.doi.org/10.1038/s41419-019-1955-9 |
Ejemplares similares
-
Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
por: Ye, Ting-Hong, et al.
Publicado: (2017) -
Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2016) -
Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2022) -
Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model
por: Yang, F, et al.
Publicado: (2015) -
Nifuroxazide ameliorates lipid and glucose metabolism in palmitate-induced HepG2 cells
por: Liu, Jing-Yi, et al.
Publicado: (2019)